References

Home

1. Frampton GM, et al. Nat Biotechnol 2013;31:1023-31.

2. Drilon A, et al. Clin Cancer Res 2015;21:3631-9.

3. Rankin A, et al. Oncologist 2016;21:1306-1314.

4. Ross JS, et al. Cancer 2016;122:2654-62.

5. Suh JH, et al. Oncologist 2016;21:684-91.

6. Hirshfield KM, et al. Oncologist 2016;21:1315-25.

7. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed October 2018).

8. FoundationOne®CDx FDA Approval, 2017. Available at:
https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf (Accessed October 2018).

9. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed October 2018).

10. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed October 2018).

11. Roche Media Release, 2018. Available at:
https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed October 2018).

12. He J, et al. Blood 2016;127:3004-14.

13. Clark TA, et al. J Mol Diagn. 2018; 20: 686-702.

14. FoundationOne®CDx Sample Report, 2018. Available at: www.rochefoundationmedicine.com/reporting (Accessed October 2018).

What We Do

1. Frampton GM, et al. Nat Biotechnol 2013;31:1023-31.

2. Drilon A, et al. Clin Cancer Res 2015;21:3631-9.

3. Rankin A, et al. Oncologist 2016;21:1306-14.

4. Ross JS, et al. Cancer 2016;122:2654-62.

5. Suh JH, et al. Oncologist 2016;21:684-91.

6. Hirshfield KM, et al. Oncologist 2016;21:1315-25

7. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed October 2018).

8. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed October 2018).

9. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed October 2018).

10. He J, et al. Blood 2016;127:3004-14.

11. Clark TA, et al.J Mol Diagn 2018; 20: 686-702.

12. Chalmers ZR, et al. Genome Med 2017;9:34.

13. Rozenblum AB, et al. J Thorac Oncol 2017;12:258-68.

14. Schrock AB, et al. Clin Cancer Res 2016;22:3281-5.

15. Ross JS, et al. Gynecol Oncol 2013;130:554-9.

16. Hall MJ, et al. J Clin Oncol 2016;34:1523-23.

17. Le DT, et al. Science. 2017;357:409-13.

18. Goodman AM, et al. Mol Cancer Ther 2017;16:2598-608.

19. Dudley JC, et al. Clin Cancer Res 2016;22:813-20.

20. Johnson DB, et al. Cancer Immunol Res 2016;4:959-67.

21. Rizvi H, et al. J Clin Oncol 2018;36:633-41.

22. Hellmann MD, et al. N Engl J Med 2018;378:2093-2104.

23. FoundationOne®CDx Sample Report, 2018. Available at:
www.rochefoundationmedicine.com/reporting (Accessed October 2018).

24. A search for “Foundation Medicine”[Affiliation] on the NCBI database resulted in 348 publications, as of October 2018. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/?term=%E2%80%9CFoundation+Medicine%E2%80%9D%5BAffiliation%5D (Accessed October 2018).

25. Foundation Medicine Publications. Available at:
https://www.foundationmedicine.com/publications (Accessed October 2018).

26. Foundation Insights Available at:
https://www.foundationmedicine.com/insights-and-trials/foundation-insights. (Accessed October 2018).

Our Services

1. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed October 2018).

2. FoundationOne®CDx FDA Approval, 2017. Available at:
https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf (Accessed October 2018).

3. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed October 2018).

4. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed October 2018).

5. FoundationOne®CDx FDA Approval Press Release, 2017. Available at:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587273.htm (Accessed October 2018).

6. FoundationOne®CDx clinical validation, 2017. Available at:
http://www.foundationmedicine.com/genomic-testing/foundation-one-cdx (Accessed October 2018).

7. Frampton GM et al. Nat Biotechnol 2013;31:1023–1031.

8. Drilon A et al. Clin Cancer Res 2015;21:3631–3639.

9. Rankin A et al. Oncologist 2016;21:1306–1314.

10. Ross JS et al. Cancer 2016;122:2654–2662.

11. Suh JH et al. Oncologist 2016;21:684–691.

12. Hirshfield KM et al. Oncologist 2016;21:1315–1325.

13. Clark TA, et al. J Mol Diagn. 2018;20:686–702.

About Us

1. Roche Media Release, 2018. Available at:
https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed October 2018).

2. Foundation Insights Available at:
https://www.foundationmedicine.com/insights-and-trials/foundation-insights. (Accessed October 2018).

3. A search for “Foundation Medicine”[Affiliation] on the NCBI database resulted in 348 publications, as of October 2018. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/?term=%E2%80%9CFoundation+Medicine%E2%80%9D%5BAffiliation%5D (Accessed October 2018).

4. Foundation Medicine Publications. Available at:
https://www.foundationmedicine.com/publications (Accessed October 2018).